Newsletter / Paid-only At Risk: COVAX Plans to Vaccinate 20% of the People in LMICs; Guest Essay: A Critique of The Independent Panel Report By Priti Patnaik / 18 May 2021
Newsletter / Paid-only Tied Funds To WHO, But Flexible Funds To Its Partners: Sustainable Financing Working Group Confronts Challenges By Priti Patnaik / 14 May 2021
Newsletter / Paid-only The dash for the pandemic treaty; Understanding the Oxygen crisis: Q&A: Robert Matiru, Unitaid By Priti Patnaik / 11 May 2021
Newsletter / Paid-only The WTO Becomes the Nerve Center for Pandemic Response By Priti Patnaik / 7 May 2021
Newsletter / Paid-only Variants of Concern & Variants of Interest: SARS-CoV-2 By Priti Patnaik / 4 May 2021
Newsletter / Paid-only Countries divided on ways to reform WHO emergency preparedness By Priti Patnaik / 30 Apr 2021
Newsletter / Paid-only COVAX counts on dose-sharing to counter vaccine crunch, vaccine diplomacy makes it worse By Priti Patnaik / 27 Apr 2021
Newsletter / Paid-only "A hole in the firewall": The WHO Foundation & WHO; "Green shoots" for TRIPS Waiver Talks? By Priti Patnaik / 23 Apr 2021
Newsletter / Paid-only India: The Quagmire for COVAX; Q&A: Hyo Yoon Kang on the financialization of intellectual property & COVID-19 By Priti Patnaik / 20 Apr 2021
Newsletter / Paid-only WHO & WTO converge on bilateral tech transfer for vaccines. What this means for the TRIPS Waiver By Priti Patnaik / 16 Apr 2021
